Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
Mohammad Shahidi‐Dadras, Azadeh Rakhshan, Arman Ahmadzadeh, Seyed Ali Hosseini, Reem Diab, Toktam Safari Giv, Fahimeh Abdollahimajd
Abstract
COVID-19 should be considered as a new triggering factor for autoimmune disorders like DM-lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID-19.
Topics & Concepts
MedicineDermatomyositisCoronavirus disease 2019 (COVID-19)Systemic lupus erythematosusOverlap syndromeDiseaseCardiomyopathyMyocarditisImmunologyAutoimmune diseasePandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Viral infectionDermatologyInternal medicineHeart failureVirusInfectious disease (medical specialty)Inflammatory Myopathies and DermatomyositisMuscle and Compartmental DisordersSkin Diseases and Diabetes